litlas
Log inCreate account

Chris Parker

Active 1976–2025

147
Papers
29,083
Citations
86
h-index
141
i10-index

Citations

Citations per year for Chris Parker1961: 1 citations1980: 1 citations1990: 1 citations1992: 2 citations1993: 2 citations1994: 2 citations1995: 5 citations1996: 4 citations1997: 7 citations1998: 9 citations1999: 7 citations2000: 15 citations2001: 24 citations2002: 13 citations2003: 28 citations2004: 31 citations2005: 46 citations2006: 50 citations2007: 71 citations2008: 72 citations2009: 110 citations2010: 137 citations2011: 118 citations2012: 153 citations2013: 173 citations2014: 189 citations2015: 223 citations2016: 224 citations2017: 228 citations2018: 270 citations2019: 929 citations2020: 1,017 citations2021: 1,030 citations2022: 750 citations2023: 586 citations2024: 882 citations2025: 389 citations2026: 26 citations1962–1979: no citations, so these years are not shown1981–1989: no citations, so these years are not shown1991: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,589 citing papers, 20.7% of this breakdownUnited Kingdom: 1,328 citing papers, 10.6% of this breakdownCanada: 758 citing papers, 6.1% of this breakdownGermany: 737 citing papers, 5.9% of this breakdownChina: 728 citing papers, 5.8% of this breakdownItaly: 723 citing papers, 5.8% of this breakdownNetherlands: 492 citing papers, 3.9% of this breakdownFrance: 489 citing papers, 3.9% of this breakdownAustralia: 457 citing papers, 3.7% of this breakdownSwitzerland: 352 citing papers, 2.8% of this breakdownSpain: 328 citing papers, 2.6% of this breakdownBelgium: 285 citing papers, 2.3% of this breakdown
0%20.7%Other 25.9%

Institutions

Fields

  • Medicine71.9%
  • Biochemistry, Genetics and Molecular Biology10.2%
  • Computer Science3.6%
  • Social Sciences3.3%
  • Neuroscience1.7%
  • Physics and Astronomy1.6%
  • Other7.7%

Topics

  • Prostate Cancer Treatment and Research16%
  • Prostate Cancer Diagnosis and Treatment13.5%
  • Radiopharmaceutical Chemistry and Applications4.3%
  • Advanced Radiotherapy Techniques3.1%
  • Cancer, Lipids, and Metabolism1.8%
  • MRI in cancer diagnosis1.7%
  • Other59.6%

Coauthors

All papers

Open in search
  1. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study

    Authors: Hashim U. Ahmed, Ahmed El‐Shater Bosaily, Louise Brown, Rhian Gabe, Richard Kaplan, Mahesh Parmar, Yolanda Collaço‐Moraes, Katie Ward, Richard Hindley, Alex Freeman, Alex Kirkham, Robert Oldroyd, Chris Parker, Mark Emberton - The Lancet 2017 cited by 3,236

  2. Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer

    Authors: Chris Parker, Sten Nilsson, Daniel Heinrich, Svein Inge Helle, Joe M. O’Sullivan, Sophie D. Fosså, Aleš Chodacki, Paweł Wiechno, John Logue, M. Seke, Anders Widmark, Dag Clement Johannessen, Peter Hoskin, David Bottomley, Nicholas D. James, A. Solberg, Isabel Syndikus, J. Kliment, Saskia Wedel, S. Boehmer, Marcos F. Dall’Oglio, Lars Franzén, Robert E. Coleman, Nicholas J. Vogelzang, C. Gillies O'Bryan-Tear, K. Staudacher, J. Garcia‐Vargas, Minghua Shan, Øyvind S. Bruland, Oliver Sartor - New England Journal of Medicine 2013 cited by 3,343

  3. Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Authors: Chris Parker, Elena Castro, Karim Fizazi, Axel Heidenreich, Piet Ost, Giuseppe Procopio, Bertrand Tombal, Silke Gillessen - Annals of Oncology 2020 cited by 953

  4. Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

    Authors: David P. Dearnaley, Isabel Syndikus, Helen Mossop, Vincent Khoo, Alison Birtle, David Bloomfield, John D. Graham, Peter Kirkbride, John Logue, Zafar Malik, Julian Money‐Kyrle, Joe M. O’Sullivan, Miguel Panades, Chris Parker, Helen Patterson, Christopher Scrase, John Staffurth, Andrew Stockdale, Jean Tremlett, Margaret Bidmead, Helen Mayles, Olivia Naismith, C. South, Annie Gao, Clare Cruickshank, Shama Hassan, Julia Pugh, Clare Griffin, Emma Hall - The Lancet Oncology 2016 cited by 1,317

  5. Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Authors: Alan Horwich, Chris Parker, C. Bangma, Vesa Kataja - Annals of Oncology 2010 cited by 600

  6. Prostate cancer

    Authors: Gerhardt Attard, Chris Parker, Rosalind A. Eeles, Fritz H. Schröder, Scott A. Tomlins, Ian F. Tannock, Charles G. Drake, Johann S. de Bono - The Lancet 2015 cited by 917

  7. Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial

    Authors: N.W. Clarke, Amin Ali, Fiona C. Ingleby, Alex Hoyle, Claire Amos, Gerhardt Attard, Chris Brawley, J. Calvert, S. Chowdhury, Audrey Cook, William Cross, David P. Dearnaley, Hassan Douis, Duncan C. Gilbert, Silke Gillessen, Robert J. Jones, Ruth E. Langley, Archie Macnair, Zafar Malik, Malcolm D. Mason, David Matheson, R. Millman, Chris Parker, A.W.S. Ritchie, Hannah Rush, John M. Russell, Janet E. Brown, S. Beesley, Alison Birtle, Lisa Capaldi, Joanna Gale, Stephanie Gibbs, Anna Lydon, Ashok Nikapota, Aurelius Omlin, Joe M. O’Sullivan, Omi Parikh, Andrew Protheroe, Sarah Rudman, Narayanan Srihari, Matthew Simms, Jacob Tanguay, Shaun Tolan, John Wagstaff, Jan Wallace, J. Wylie, Anjali Zarkar, Matthew R. Sydes, Mahesh Parmar, Nicholas D. James - Annals of Oncology 2019 cited by 398

  8. Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial

    Authors: Matthew R. Smith, Chris Parker, Fred Saad, Kurt Miller, Bertrand Tombal, Quan Sing Ng, Martin Boegemann, Vsevolod Matveev, Josep M. Piulats, Luis Eduardo Rosa Zucca, Oleg Karyakin, Go Kimura, Nobuaki Matsubara, William Carlos Nahas, Franco Nolè, Eli Rosenbaum, Axel Heidenreich, Yoshiyuki Kakehi, Amily Zhang, Heiko Krissel, Michael Teufel, Junwu Shen, Volker Jean Wagner, Celestia S. Higano - The Lancet Oncology 2019 cited by 397

  9. Phase III Trial of PROSTVAC in Asymptomatic or Minimally Symptomatic Metastatic Castration-Resistant Prostate Cancer

    Authors: James L. Gulley, Michael Borre, Nicholas J. Vogelzang, Siobhan Ng, Neeraj Agarwal, Chris Parker, David Pook, Per Rathenborg, Thomas W. Flaig, Joan Carles, Fred Saad, Neal D. Shore, Liddy Chen, Christopher R. Heery, Winald R. Gerritsen, Frank Priou, Niels Christian Langkilde, A I Novikov, Philip W. Kantoff - Journal of Clinical Oncology 2019 cited by 278

  10. Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial

    Authors: Chris Parker, Nicholas D. James, Chris Brawley, Noel W. Clarke, Adnan Ali, Claire Amos, Gerhardt Attard, Simon Chowdhury, Adrian Cook, William Cross, David P. Dearnaley, Hassan Douis, Duncan C. Gilbert, Clare Gilson, Silke Gillessen, Alex Hoyle, Robert J. Jones, Ruth E. Langley, Zafar Malik, Malcolm D. Mason, David Matheson, Robin Millman, Mary Rauchenberger, Hannah Rush, Martin Russell, Hannah Sweeney, Amit Bahl, Alison Birtle, Lisa Capaldi, Omar Din, Daniel Ford, Joanna Gale, Ann Henry, Peter Hoskin, M. Kagzi, Anna Lydon, Joe M. O’Sullivan, Sangeeta Paisey, Omi Parikh, Delia Pudney, Vijay Ramani, Peter Robson, Narayanan Srihari, Jacob Tanguay, Mahesh Parmar, Matthew R. Sydes, for the STAMPEDE Trial Collaborative Group - PLoS Medicine 2022 cited by 121

  11. Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017

    Authors: Silke Gillessen, Gerhardt Attard, Tomasz M. Beer, Himisha Beltran, Alberto Bossi, Robert G. Bristow, Brett S. Carver, Daniel Castellano, Byung Ha Chung, Noel W. Clarke, Gedske Daugaard, Ian D. Davis, Johann S. de Bono, Rodolfo Borges dos Reis, Charles G. Drake, Rosalind A. Eeles, Eleni Efstathiou, Christopher P. Evans, Stefano Fanti, Felix Y. Feng, Karim Fizazi, Mark Frydenberg, Martin Gleave, Susan Halabi, Axel Heidenreich, Celestia S. Higano, Nicolas James, Philip W. Kantoff, Pirkko‐Liisa Kellokumpu‐Lehtinen, Raja B. Khauli, Gero Kramer, Chris Logothetis, Fernando Cotait Maluf, Alicia K. Morgans, Michael J. Morris, Nicolas Mottet, Vedang Murthy, William Oh, Piet Ost, Anwar R. Padhani, Chris Parker, Colin C. Pritchard, Mack Roach, Mark A. Rubin, Charles J. Ryan, Fred Saad, Oliver Sartor, Howard I. Scher, Avishay Sella, Neal D. Shore, Matthew R. Smith, Howard R. Soule, Cora N. Sternberg, Hiroyoshi Suzuki, Christopher J. Sweeney, Matthew R. Sydes, Ian F. Tannock, Bertrand Tombal, R. Valdagni, Thomas Wiegel, Aurelius Omlin - European Urology 2017 cited by 643

  12. Prevention and early detection of prostate cancer

    Authors: Jack Cuzick, Mangesh A. Thorat, Gerald L. Andriole, Otis W. Brawley, Powel H. Brown, Zoran Čulig, Rosalind A. Eeles, Leslie G. Ford, Freddie C. Hamdy, Lars Holmberg, Dragan Ilić, Timothy J. Key, Carlo La Vecchia, Hans Lilja, Michael Marberger, Frank L. Meyskens, Lori M. Minasian, Chris Parker, Howard L. Parnes, Sven Perner, Harry G. Rittenhouse, Jack A. Schalken, Hans Peter Schmid, Bernd J. Schmitz‐Dräger, Fritz H. Schröder, Arnulf Stenzl, Bertrand Tombal, Timothy J Wilt, Alicja Wolk - The Lancet Oncology 2014 cited by 492

  13. PTEN Protein Loss and Clinical Outcome from Castration-resistant Prostate Cancer Treated with Abiraterone Acetate

    Authors: Roberta Ferraldeschi, Daniel Nava Rodrigues, Ruth Riisnaes, Susana Miranda, Ines Figueiredo, Pasquale Rescigno, Praful Ravi, Carmel Pezaro, Aurelius Omlin, David Lorente, Zafeiris Zafeiriou, Joaquı́n Mateo, Amelia Altavilla, Spyridon Sideris, Diletta Bianchini, Emily Grist, Khin Thway, Raquel Pérez-López, Nina Tunariu, Chris Parker, David P. Dearnaley, Alison Reid, Gerhardt Attard, Johann S. de Bono - European Urology 2014 cited by 258

  14. Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5‐year follow‐up results from the STAMPEDE randomised trial (NCT00268476)

    Authors: Nicholas D. James, Noel W. Clarke, Adrian Cook, Adnan Ali, Alex Hoyle, Gerhardt Attard, Chris Brawley, Simon Chowdhury, William Cross, David P. Dearnaley, Johann S. de Bono, Carlos Díaz-Montaña, Duncan C. Gilbert, Silke Gillessen, Clare Gilson, Robert J. Jones, Ruth E. Langley, Zafar Malik, David Matheson, Robin Millman, Chris Parker, Cheryl Pugh, Hannah Rush, John M. Russell, Dominik Berthold, Michelle Buckner, Malcolm D. Mason, A.W.S. Ritchie, Alison Birtle, Susannah Brock, Prantik Das, Dan Ford, Joanna Gale, Warren Grant, Emma Gray, Peter Hoskin, Mohammad Muneeb Khan, Caroline Manetta, Neil McPhail, Joe M. O’Sullivan, Omi Parikh, Carla Perna, Carmel Pezaro, Andrew Protheroe, Angus Robinson, Sarah Maria Rudman, D.J. Sheehan, Narayanan Srihari, Isabel Syndikus, Jacob Tanguay, Carys Thomas, Salil Vengalil, John Wagstaff, James Wylie, Mahesh Parmar, Matthew R. Sydes, for the STAMPEDE Trials Collaborative Group - International Journal of Cancer 2022 cited by 77

  15. When Transparency Fails: Bias and Financial Incentives in Ridesharing Platforms

    Authors: Jorge Mejia, Chris Parker - Management Science, Manag. Sci. 2018 cited by 134

  16. Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019

    Authors: Silke Gillessen, Gerhardt Attard, Tomasz M. Beer, Himisha Beltran, Anders Bjartell, Alberto Bossi, Alberto Briganti, Robert G. Bristow, Kim N., Noel W. Clarke, Ian D. Davis, Johann S. de Bono, Charles G. Drake, Ignacio Durán, Rosalind A. Eeles, Eleni Efstathiou, Christopher P. Evans, Stefano Fanti, Felix Y. Feng, Karim Fizazi, Mark Frydenberg, Martin Gleave, Susan Halabi, Axel Heidenreich, Daniel Heinrich, Celestia S. Higano, Michael S. Hofman, Maha Hussain, Nicholas D. James, Ravindran Kanesvaran, Philip W. Kantoff, Raja B. Khauli, Raya Leibowitz‐Amit, Chris Logothetis, Fernando Cotait Maluf, Robin Millman, Alicia K. Morgans, Michael J. Morris, Nicolas Mottet, Hind M’rabti, Declan G. Murphy, Vedang Murthy, William Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Chris Parker, Darren M.C. Poon, Colin C. Pritchard, Robert E. Reiter, Mack Roach, Mark A. Rubin, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Oliver Sartor, Howard I. Scher, Neal D. Shore, Eric J. Small, Matthew R. Smith, Howard R. Soule, Cora N. Sternberg, Thomas Steuber, Hiroyoshi Suzuki, Christopher J. Sweeney, Matthew R. Sydes, Mary-Ellen Taplin, Bertrand Tombal, Levent Türkeri, Inge M. van Oort, A. Zapatero, Aurelius Omlin - European Urology 2020 cited by 395

  17. Best Approaches and Updates for Prostate Cancer Biochemical Recurrence

    Authors: Nicholas I. Simon, Chris Parker, Thomas A. Hope, Channing J. Paller - American Society of Clinical Oncology Educational Book 2022 cited by 69

  18. Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021

    Authors: Silke Gillessen, Andrew J. Armstrong, G. Attard, Tomasz M. Beer, Himisha Beltran, Anders Bjartell, Alberto Bossi, Alberto Briganti, Robert G. Bristow, Muhammad Bulbul, Orazio Caffo, Kim N., Caroline S. Clarke, Noel W. Clarke, Ian D. Davis, Johann S. de Bono, Ignacio Durán, Rosalind A. Eeles, Eleni Efstathiou, Jason A. Efstathiou, Onyeanunam Ngozi Ekeke, Christopher P. Evans, Stefano Fanti, Felix Y. Feng, Karim Fizazi, Mark Frydenberg, Dan George, Martin Gleave, Susan Halabi, Daniel Heinrich, Celesta Higano, Michael S. Hofman, Maha Hussain, Nick James, Robert J. Jones, Ravindran Kanesvaran, Raja B. Khauli, Laurence Klotz, Raya Leibowitz‐Amit, Chris Logothetis, Fernando Cotait Maluf, Robin Millman, Alicia K. Morgans, Michael J. Morris, Nicolas Mottet, Hind M’rabti, Declan G. Murphy, Vedang Murthy, William Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Chris Parker, Darren M.C. Poon, Colin C. Pritchard, Danny Rabah, Dana E. Rathkopf, Rob E. Reiter, Mark A. Rubin, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Oliver Sartor, Howard I. Scher, Neal D. Shore, Iwona Skoneczna, Eric J. Small, Matthew R. Smith, Howard R. Soule, Daniel E. Spratt, Cora N. Sternberg, Hiroyoshi Suzuki, Christopher J. Sweeney, Matthew R. Sydes, Mary‐Ellen Taplin, Derya Tilki, Bertrand Tombal, Levent Türkeri, Hiroji Uemura, Hirotsugu Uemura, Inge M. van Oort, Kosj Yamoah, Dingwei Ye, A. Zapatero, Aurelius Omlin - European Urology 2022 cited by 128

  19. Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC)

    Authors: Silke Gillessen, Fabio Turco, Ian D. Davis, Jason A. Efstathiou, Karim Fizazi, Nicholas D. James, Neal D. Shore, Eric J. Small, Matthew R. Smith, Christopher J. Sweeney, Bertrand Tombal, Thomas Zilli, Neeraj Agarwal, Emmanuel S. Antonarakis, Ana M. Aparicio, Andrew J. Armstrong, Diogo Assed Bastos, Gerhardt Attard, Karol Axcrona, Mouna Ayadi, Himisha Beltran, Anders Bjartell, Pierre Blanchard, María T. Bourlon, Alberto Briganti, Muhammad Bulbul, Consuelo Buttigliero, Orazio Caffo, Daniel Castellano, Elena Castro, Heather H. Cheng, Kim N., Caroline S. Clarke, Noel W. Clarke, Johann S. de Bono, Maria De Santis, Ignacio Durán, Eleni Efstathiou, Onyeanunam Ngozi Ekeke, Tamer I H El Nahas, Louise Emmett, Stefano Fanti, Omolara Fatiregun, Felix Y. Feng, Peter C.C. Fong, Valérie Fonteyne, Nicola Fossati, Daniel J. George, Martin Gleave, Gwénaëlle Gravis, Susan Halabi, Daniel Heinrich, Ken Herrmann, Michael S. Hofman, Thomas A. Hope, Lisa G. Horvath, Maha Hussain, Barbara Alicja Jereczek‐Fossa, Robert J. Jones, Anthony M. Joshua, R. Kanesvaran, Daniel Keizman, Raja B. Khauli, Gero Kramer, Stacy Loeb, Brandon A. Mahal, Fernando Cotait Maluf, Joaquı́n Mateo, David Matheson, Mika Matikainen, Ray McDermott, Rana R. McKay, Niven Mehra, Axel S. Merseburger, Alicia K. Morgans, Michael J. Morris, Hind M’rabti, Deborah Mukherji, Declan G. Murphy, Vedang Murthy, Shingai B.A. Mutambirwa, Paul L. Nguyen, William Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Chris Parker, Darren M.C. Poon, Colin C. Pritchard, Danny Rabah, Dana E. Rathkopf, Robert E. Reiter, Raphaële Renard‐Penna, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Shahneen Sandhu, Oliver A. Sartor, Edward M. Schaeffer, Howard I. Scher and 21 more - European Urology 2024 cited by 115

  20. Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial

    Authors: Chris Parker, Howard Kynaston, Adrian Cook, Noel W. Clarke, Charles Catton, William Cross, Peter M Petersen, Raj Persad, Cheryl Pugh, Fred Saad, John Logue, Heather Payne, Lorna C Bower, Chris Brawley, Mary Rauchenberger, Maroie Barkati, David Bottomley, Klaus Brasso, Hans T. Chung, Peter Chung, Ruth Conroy, Alison Falconer, V. Ford, Chee Goh, Catherine Heath, Nicholas D. James, Charmaine Kim‐Sing, Ravi Kodavatiganti, Shawn Malone, Stephen Morris, Abdenour Nabid, A. Ong, Rakesh Raman, Sree Rodda, Paula Wells, Jane Worlding, Wendy R. Parulekar, Mahesh Parmar, Matthew R. Sydes, Claire Amos, Katherine Beaney, Katharine Bellenger, Chris Brawley, Christina Chung, Adrian Cook, Andrew Embleton, Silvia Forcat, Cindy Goldstein, Jenna Grabey, Dominic Hague, Anna Herasimtschuk, Zaheer Islam, Gordana Jovic, Christos Maniatis, Lindsey Masters, Fatima Mohamed, Rachel Morgan, Claire Murphy, Dipa Noor, Max Parmar, Paul Patterson, Holly Pickering, Cheryl Pugh, Mary Rauchenberger, Helena Ribeiro, Carol Roach, Fatimah Seray-Wurie, Preetha Shaji, Hannah Sims, Ben Spittle, Matthew Sydes, Nancy Tappenden, Lilian Tsang, Barbara Uscinska, Teddy Brown, Sue Casey, Cathy Davidson, Conor Dellar, Mandy Fletcher, Ralph Meyer, Karen Murphy, Wendy Parulekar, Harriet Richardson, Karen Richardson, Kate Whelan, Donald Bissett, Shelagh Bonner-Shand, Judith Grant, Rory Lynch, Graham MacDonald, Marie McWilliam, Rachel Moir, Sue Rodwell, Kirsty Shearer, Margaret Smith, Louise Binns, Maxine Briggs, Simon Brown, Nathalie Casanova, Katy Clark and 2,443 more - The Lancet 2024 cited by 72

  21. How to design fashion retail's virtual reality platforms

    Authors: Liangchao Xue, Chris Parker, Cathy Hart - International Journal of Retail & Distribution Management 2020 cited by 75

  22. Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol

    Authors: Matthew R. Sydes, Melissa Spears, Malcolm D. Mason, Noel W. Clarke, David P. Dearnaley, Johann S. de Bono, Gerhardt Attard, S. Chowdhury, William Cross, Silke Gillessen, Zafar Malik, Robert J. Jones, Chris Parker, A.W.S. Ritchie, John M. Russell, R. Millman, David Matheson, Claire Amos, Clare Gilson, Alison Birtle, Susannah Brock, Lisa Capaldi, P. Chakraborti, Ananya Choudhury, Linda Evans, Daniel Ford, Joanna Gale, Stephanie Gibbs, Duncan C. Gilbert, Robert Hughes, Duncan B. McLaren, J.F. Lester, Ashok Nikapota, Joe M. O’Sullivan, Omi Parikh, C. Peedell, Andrew Protheroe, Sarah Maria Rudman, Richard Shaffer, Denise Sheehan, Matthew Simms, Narayanan Srihari, Raeto T. Strebel, Santhanam Sundar, Shaun Tolan, D. Tsang, M. Varughese, John Wagstaff, Mahesh Parmar, Nicholas D. James - Annals of Oncology 2018 cited by 250

  23. How augmented reality can enhance fashion retail: a UX design perspective

    Authors: Liangchao Xue, Chris Parker, Cathryn A. Hart - International Journal of Retail & Distribution Management 2022 cited by 63

  24. Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial

    Authors: Chris Parker, Noel W. Clarke, Adrian Cook, Howard Kynaston, Charles Catton, William Cross, Peter M Petersen, Raj Persad, Fred Saad, Lorna C Bower, John Logue, Heather Payne, Silvia Forcat, Cindy Goldstein, Claire Murphy, J R Anderson, Maroie Barkati, David Bottomley, Jennifer Mary Rose Branagan, Ananya Choudhury, Peter Chung, Lyn Cogley, Chee Goh, Peter Hoskin, Vincent Khoo, Shawn Malone, Lindsey Masters, Stephen Morris, Abdenour Nabid, A. Ong, Rakesh Raman, Kathryn Tarver, Alison Tree, Jane Worlding, James Wylie, Anjali Zarkar, Wendy R. Parulekar, Mahesh Parmar, Matthew R. Sydes, Claire Amos, Katherine E. Beaney, Katharine Bellenger, Chris Brawley, Christina Chung, Adrian Cook, Andrew Embleton-Thirsk, Silvia Forcat, Cindy Goldstein, Jenna Grabey, Dominic Hague, Anna Herasimtschuk, Zaheer Islam, Gordana Jovic, C. Maniatis, Lindsey Masters, Fatima Mohamed, Rachel C. Morgan, Claire Murphy, Dipa Noor, Max Parmar, Paul R. Patterson, Holly Pickering, Cheryl Pugh, Mary Rauchenberger, Helena Ribeiro, Carol Roach, Fatimah Seray-Wurie, Preetha Shaji, Hannah Sims, Ben Spittle, Matthew R. Sydes, Nancy Tappenden, Lilian Tsang, Barbara Uscinska, Teddy Brown, Sue Casey, Cathy N. Davidson, Conor Dellar, Mandy Fletcher, Ralph M. Meyer, Karen Murphy, Wendy R. Parulekar, Harriet Richardson, K. Martin Richardson, Kate Whelan, Donald Bissett, Shelagh Bonner-Shand, Judith Grant, Rory Lynch, Graham Macdonald, Marie McWilliam, Rachel Moir, Sue Rodwell, Kirsty Shearer, Margaret Smith, Louise Binns, Maxine Briggs, Simon Brown, Nathalie Casanova, Katy M. Clark and 2,443 more - The Lancet 2024 cited by 49